Compare VIASP & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Via Renewables Inc. 8.75% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock
Current Price
| Metric | VIASP | MDAIW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 160 | 78 |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | VIASP | MDAIW |
|---|---|---|
| Price | $25.81 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 35.6K |
| Earning Date | N/A | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,264,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 44.52 |
| 52 Week Low | N/A | $0.08 |
| 52 Week High | N/A | $0.90 |
| Indicator | VIASP | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 56.21 |
| Support Level | $25.65 | $0.38 |
| Resistance Level | $25.91 | $0.59 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 98.66 | 71.47 |
Via Renewables Inc is an independent retail energy services company. It provides residential and commercial customers in competitive markets across the United States with an alternative choice for natural gas and electricity. Via Renewables offers its customers a variety of product and service choices, including stable and predictable energy costs and green product alternatives. Its segments are Retail Electricity and Retail Natural Gas. The key revenue is derived from the Retail Electricity segment in which the company purchases electricity supply through physical and financial transactions with market counterparties and ISOs and supplies electricity to residential and commercial consumers pursuant to fixed-price and variable-price contracts.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.